153 related articles for article (PubMed ID: 31001473)
1. Genome-Wide and Phenotypic Evaluation of Stem Cell Progenitors Derived From
Daouk R; Hassane M; Bahmad HF; Sinjab A; Fujimoto J; Abou-Kheir W; Kadara H
Front Oncol; 2019; 9():207. PubMed ID: 31001473
[TBL] [Abstract][Full Text] [Related]
2. Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.
Fujimoto J; Nunomura-Nakamura S; Liu Y; Lang W; McDowell T; Jakubek Y; Ezzeddine D; Kapere Ochieng J; Petersen J; Davies G; Fukuoka J; Wistuba II; Ehli E; Fowler J; Scheet P; Kadara H
Int J Cancer; 2017 Oct; 141(8):1589-1599. PubMed ID: 28653505
[TBL] [Abstract][Full Text] [Related]
3. Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma Development.
Treekitkarnmongkol W; Hassane M; Sinjab A; Chang K; Hara K; Rahal Z; Zhang J; Lu W; Sivakumar S; McDowell TL; Kantrowitz J; Zhou J; Lang W; Xu L; Ochieng JK; Nunomura-Nakamura S; Deng S; Behrens C; Raso MG; Fukuoka J; Reuben A; Ostrin EJ; Parra E; Solis LM; Spira AE; McAllister F; Cascone T; Wistuba II; Moghaddam SJ; Scheet PA; Fujimoto J; Kadara H
Am J Respir Crit Care Med; 2021 Jan; 203(1):90-101. PubMed ID: 32730093
[No Abstract] [Full Text] [Related]
4. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
Kadara H; Choi M; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Yoo Y; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Wistuba II; Herbst RS
Ann Oncol; 2017 Jan; 28(1):75-82. PubMed ID: 27687306
[TBL] [Abstract][Full Text] [Related]
5. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
6. Identification of Sca-1
Yin H; Jiang Z; Feng X; Ji Z; Jin W
Oncogene; 2020 Apr; 39(18):3754-3773. PubMed ID: 32157214
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis reveals distinct subtypes with therapeutic implications in KRAS-mutant lung adenocarcinoma.
Liu K; Guo J; Liu K; Fan P; Zeng Y; Xu C; Zhong J; Li Q; Zhou Y
EBioMedicine; 2018 Oct; 36():196-208. PubMed ID: 30268834
[TBL] [Abstract][Full Text] [Related]
8.
Wang X; Min S; Liu H; Wu N; Liu X; Wang T; Li W; Shen Y; Wang H; Qian Z; Xu H; Zhao C; Chen Y
EMBO Mol Med; 2019 Jun; 11(6):. PubMed ID: 31036704
[TBL] [Abstract][Full Text] [Related]
9. Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung Adenocarcinoma.
Kantrowitz J; Sinjab A; Xu L; McDowell TL; Sivakumar S; Lang W; Nunomura-Nakamura S; Fukuoka J; Nemer G; Darwiche N; Chami H; Tfayli A; Wistuba II; Scheet P; Fujimoto J; Spira AE; Kadara H
Cancer Prev Res (Phila); 2018 Apr; 11(4):237-248. PubMed ID: 29382653
[TBL] [Abstract][Full Text] [Related]
10. Whole Transcriptome Sequencing Analysis of Cancer Stem/Progenitor Cells Obtained from Mouse Lung Adenocarcinomas.
Sinjab A; Daouk R; Abou-Kheir W; Kadara H
Methods Mol Biol; 2021; 2279():187-198. PubMed ID: 33683695
[TBL] [Abstract][Full Text] [Related]
11. circGprc5a Promoted Bladder Oncogenesis and Metastasis through Gprc5a-Targeting Peptide.
Gu C; Zhou N; Wang Z; Li G; Kou Y; Yu S; Feng Y; Chen L; Yang J; Tian F
Mol Ther Nucleic Acids; 2018 Dec; 13():633-641. PubMed ID: 30497053
[TBL] [Abstract][Full Text] [Related]
12. Targeting HSPA1A in ARID2-deficient lung adenocarcinoma.
Wang X; Wang Y; Fang Z; Wang H; Zhang J; Zhang L; Huang H; Jiang Z; Jin Y; Han X; Hou S; Zhou B; Meng F; Chen L; Wong KK; Liu J; Zhang Z; Zhang X; Chen H; Sun Y; Hu L; Ji H
Natl Sci Rev; 2021 Oct; 8(10):nwab014. PubMed ID: 34858604
[TBL] [Abstract][Full Text] [Related]
13. An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer.
Wang H; Lv Q; Xu Y; Cai Z; Zheng J; Cheng X; Dai Y; Jänne PA; Ambrogio C; Köhler J
EBioMedicine; 2019 Nov; 49():106-117. PubMed ID: 31668570
[TBL] [Abstract][Full Text] [Related]
14. Gprc5a depletion enhances the risk of smoking-induced lung tumorigenesis and mortality.
Guo W; Hu M; Wu J; Zhou A; Liao Y; Song H; Xu D; Kuang Y; Wang T; Jing B; Li K; Ling J; Wen D; Wu W
Biomed Pharmacother; 2019 Jun; 114():108791. PubMed ID: 30901718
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
16. A mutant KRAS-induced factor REG4 promotes cancer stem cell properties via Wnt/β-catenin signaling.
Hwang JH; Yoon J; Cho YH; Cha PH; Park JC; Choi KY
Int J Cancer; 2020 May; 146(10):2877-2890. PubMed ID: 31605540
[TBL] [Abstract][Full Text] [Related]
17. KRAS Activation in Gastric Adenocarcinoma Stimulates Epithelial-to-Mesenchymal Transition to Cancer Stem-Like Cells and Promotes Metastasis.
Yoon C; Till J; Cho SJ; Chang KK; Lin JX; Huang CM; Ryeom S; Yoon SS
Mol Cancer Res; 2019 Sep; 17(9):1945-1957. PubMed ID: 31217166
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of Differentiation-1 Sustains Mutant
Román M; López I; Guruceaga E; Baraibar I; Ecay M; Collantes M; Nadal E; Vallejo A; Cadenas S; Miguel ME; Jang JH; Martin-Uriz PS; Castro-Labrador L; Vilas-Zornoza A; Lara-Astiaso D; Ponz-Sarvise M; Rolfo C; Santos ES; Raez LE; Taverna S; Behrens C; Weder W; Wistuba II; Vicent S; Gil-Bazo I
Cancer Res; 2019 Feb; 79(3):625-638. PubMed ID: 30563891
[TBL] [Abstract][Full Text] [Related]
19. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
[TBL] [Abstract][Full Text] [Related]
20. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.
Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW
Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
